» Authors » Orly Vardeny

Orly Vardeny

Explore the profile of Orly Vardeny including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 173
Citations 8756
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
DeVore A, Walsh M, Vardeny O, Albert N, Desai A
JACC Heart Fail . 2025 Jan; PMID: 39797845
Data from large-scale, randomized, controlled trials demonstrate that contemporary treatments for heart failure (HF) can substantially improve morbidity and mortality. Despite this, observed outcomes for patients living with HF are...
2.
Tisdale R, Cao F, Skye M, Vardeny O, Sallam K, Kalwani N, et al.
J Card Fail . 2025 Jan; PMID: 39778675
Background: Guidelines recommend timely follow-up with a cardiology specialist for patients hospitalized with heart failure (HF), but it is unknown whether the timeliness of specialty cardiovascular care after discharge correlates...
3.
Wang X, Vardeny O, Claggett B, Vaduganathan M, Hegde S, Skali H, et al.
Eur J Heart Fail . 2024 Dec; 27(1):96-106. PMID: 39675788
Aims: To evaluate clinical outcomes, echocardiographic features, and the efficacy and safety of sacubitril/valsartan compared to valsartan across age groups in the PARAGON-HF trial. Methods And Results: A total of...
4.
Rahafrooz M, Elbers D, Gopal J, Ren J, Chan N, Yildirim C, et al.
J Am Med Inform Assoc . 2024 Dec; 32(2):349-356. PMID: 39671451
Objective: Event capture in clinical trials is resource-intensive, and electronic medical records (EMRs) offer a potential solution. This study develops algorithms for EMR-based death and hospitalization capture and compares them...
5.
Chimura M, Wang X, Jhund P, Henderson A, Claggett B, Desai A, et al.
JAMA Cardiol . 2024 Nov; 10(1):59-70. PMID: 39550721
Importance: Sex is associated with the clinical presentation, outcomes, and response to treatment in patients with heart failure (HF). However, little is known about the safety and efficacy of treatment...
6.
Vardeny O, Vaduganathan M, Claggett B, Desai A, Jhund P, Lam C, et al.
JAMA Cardiol . 2024 Nov; 10(1):42-48. PMID: 39550716
Importance: Treatment with finerenone, a nonsteroidal mineralocorticoid receptor antagonist (MRA), improved outcomes in patients with heart failure with mildly reduced or preserved ejection fraction in FINEARTS-HF, but was associated with...
7.
Marti-Castellote P, Reeder C, Claggett B, Claggett B, Singh P, Lau E, et al.
Circ Heart Fail . 2024 Nov; 18(1):e012514. PMID: 39549261
Background: Medical record review by a physician clinical events committee is the gold standard for identifying cardiovascular outcomes in clinical trials, but is labor-intensive and poorly reproducible. Automated outcome adjudication...
8.
Halaseh R, Sauer A, Vardeny O, Canonico M, Harrington J, Svetlichnaya J, et al.
Heart Fail Rev . 2024 Oct; 30(2):287-291. PMID: 39476221
No abstract available.
9.
Peikert A, Solomon S, Vardeny O
JAMA Cardiol . 2024 Oct; 9(12):1173-1174. PMID: 39412790
No abstract available.
10.
Matsumoto S, Shen L, Henderson A, Bohm M, Desai A, Kober L, et al.
J Am Coll Cardiol . 2024 Sep; 84(18):1685-1700. PMID: 39320292
Background: Hypotension is an important clinical problem in heart failure (HF). Objectives: This study sought to examine the association between asymptomatic vs symptomatic hypotension and outcomes in PARADIGM-HF (Prospective Comparison...